Early-phase clinical trials support their safety and suggest potential efficacy in reducing craving
However, like any medication, semaglutide comes with its set of potential side effects
Todays GLP1 trials are investigating breakthrough applications in sleep apnea management, addiction treatment, cardiovascular disease prevention, non-alcoholic steatohepatitis (NASH), neurodegenerative diseases like Alzheimers and Parkinsons, and PCOS management
For a 200-pound individual, this translates to approximately 17-20 pounds
People with Digestive Issues : Individuals with digestive conditions such as Crohns disease, celiac disease, or irritable bowel syndrome (IBS) may have difficulty absorbing B12 from food
The Foundations of Intermittent Fasting Intermittent fasting is more than just a trend